Archive · 17 Sep 2026
Centre Asks States to Act Against Unproven Stem Cell Therapies
The Union health ministry has told states to take action against unproven stem cell treatments.
These treatments are being offered for illnesses where they have not been shown to work.
Doctors who provide, prescribe, or advertise them without approval could be accused of professional misconduct.
The National Medical Commission issued a warning to doctors.
Doctors may face disciplinary action under medical ethics rules.
Clinics may also face penalties or lose their licences.
However, the clinical-establishments law applies only in 19 states and Union Territories that have adopted it.
The medical ethics rules apply across India.
The Union health ministry asked states to act against unproven stem cell therapies.
The advisory covers therapies offered for conditions where effectiveness has not been established.
The National Medical Commission warned that unauthorised treatment, prescriptions, or advertising may constitute professional misconduct.
Doctors may face disciplinary action under Indian Medical Council professional-ethics regulations.
Clinical establishments may face penalties or licence cancellation in the 19 states and Union Territories that adopted the relevant Act.
- Who
- The Union health ministry, the National Medical Commission, doctors, clinical establishments, and state authorities.
- What
- States have been asked to act against unauthorised or unproven stem cell therapies, while doctors and clinics face possible disciplinary or regulatory penalties.
- When
- The advisory refers to a Supreme Court judgment from earlier this year; the article does not give the advisory’s date.
- Where
- Across India, with action under the Clinical Establishments Act limited to 19 states and Union Territories that have adopted it.
- Why
- To address stem cell therapies offered for conditions for which they have not yet been proven effective.
- Issuing authority
- Union health ministry
- Professional regulator
- National Medical Commission
- Potential doctor violation
- Unauthorised administration, prescription, or advertisement of stem cell therapy beyond approved indications
- Possible doctor consequence
- Disciplinary action under Indian Medical Council professional-ethics regulations
- Possible clinic consequences
- Penalties and licence cancellation
- Clinical-establishments law coverage
- Limited to 19 states and Union Territories that have adopted the Act
- National capital status
- The Clinical Establishments Act has not yet been implemented in the national capital